European Lung Cancer Congress (ELCC) 2025

European Lung Cancer Congress (ELCC) 2025 is organized by European Society for Medical Oncology (ESMO), International Association for the Study of Lung Cancer (IASLC) and will be held from Mar 26 - 29, 2025 at Paris Expo Porte de Versailles, Paris, Ile-de-France, France.

Description:
The European Lung Cancer Congress is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.

Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists all benefit from its comprehensive and stimulating programme.

Make sure you connect to this highly interactive meeting and share your expertise with lung cancer specialists from all over the world.

The European Lung Cancer Congress 2025 will provide insights into the prevention, diagnosis and biology-informed, multi-disciplinary management of thoracic malignancies. Specifically, the Congress will include educational and scientific sessions covering:

• Prevention, screening and early diagnosis of thoracic tumours;
• Recent developments in molecular characterization of  lung cancer;
• New breakthroughs from immunologic and targeted therapies;
• The evolving role of multidisciplinary decision-making in lung cancer;
• State of the art for NSCLC, SCLC, mesothelioma and mediastinal tumours

Learning Objectives:

• Learn about novel biomarker-guided treatment modalities for patients with lung cancer
• Be update on the optimal use of immunotherapy to treat patients with lung cancer
• Learn how to best sequence or combine multimodal therapies in common and rare thoracic tumours
• Update on novel and targeted therapies to treat patients with lung cancer.
• Review the emerging contribution of precision medicine, liquid biopsies, omics and AI technologies for the optimal management of thoracic tumor